BAM
TWST icon

Belpointe Asset Management’s Twist Bioscience TWST Stock Holding History

Belpointe Asset Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-101
Closed -$1.52K – 3184
2023
Q1 		$1.52K Hold
101
– – ﹤0.01% 3390
2022
Q4 		$2.39K Buy
+101
New +$2.93K ﹤0.01% 3199

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Belpointe Asset Management's TWST Position: Q2 2023 in Review

Belpointe Asset Management sold out of Twist Bioscience (TWST) in Q2 2023, closing a stake of 101 shares — an estimated $1.52K sold.

Belpointe Asset Management first reported a position in TWST in Q4 2022 and held it in 2 quarters. The position peaked at $2.39K in Q4 2022. 193 funds tracked by Wall St. Rank hold TWST as of Q2 2023.

  • Belpointe Asset Management reported no remaining Twist Bioscience position as of Q2 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 101 Twist Bioscience shares in Q2 2023, an estimated $1.52K.
  • Belpointe Asset Management first reported a position in Twist Bioscience in Q4 2022 and held it in 2 quarters.
  • Belpointe Asset Management's Twist Bioscience position peaked at $2.39K in Q4 2022.
  • 193 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2023.

Based on Belpointe Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.